Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Bioscience Investment topic
No spam. Unsubscribe anytime.
Committee advances bioscience equity fund to invest state dollars alongside private capital
Summary
Senate Bill 119 would create an evergreen bioscience development fund to invest state money alongside private co‑investors in New Mexico bioscience startups; the committee approved a due‑pass motion after sponsors described guardrails to limit risk and require in‑state employment.
Senate Bill 119 (presented as "1 19" in the transcript) would establish a bioscience development fund that invests state dollars as equity in New Mexico‑based bioscience companies alongside private co‑investors. The sponsor said the fund is intended to be evergreen: returns from successful exits would be recycled into new investments.
"This bill creates an evergreen bioscience development fund through equity investments in companies with the potential for financial returns which would be reinvested into the fund for future investments to support other New Mexico based bioscience companies," the sponsor said during the committee presentation. The bill pairs public investment with private capital at a required co‑investment ratio of 2 private dollars for every state dollar, the sponsor said.
Sponsor testimony and witnesses emphasized accountability features. The bill requires companies to maintain a minimum in‑state workforce during an agreed period (the sponsor cited a five‑year stay requirement in response to prior concerns from the governor's office) and to meet job‑creation and salary minimums as conditions of investment. The sponsor said companies must maintain a minimum in‑state workforce of five employees with a minimum median annual salary of $60,000 as a condition of investment; investments would be made in tranches tied to milestones, and the Secretary of Economic Development and Department of Finance and Administration must sign off on deals.
The sponsor described matching and tranche mechanics during committee questions: private investors would bring capital and private‑sector due diligence; state investments would be smaller, milestone‑driven and accompanied by job‑retention conditions to reduce the risk that companies take public funds and leave the state.
Supporters included the New Mexico Chamber of Commerce, the Bioscience Authority, industry groups and the New Mexico Biotechnology and Biomedical Association. Witnesses said the bill targets high‑wage jobs and commercialization of university and national‑lab research and argued that neighboring states compete with such investment vehicles.
Committee members asked about safeguards, milestones and the veto the governor issued the prior session. Sponsors said they had discussed concerns with the governor’s office and added employee retention and milestone provisions to address previous objections.
The committee approved a due‑pass motion by roll call, 10 yes, 0 no.
Votes at a glance: due pass motion approved, 10–0.
